Keywords: Cancer, Cancer
Motivation: We demonstrated diffuse-fibrosis and dense-fibrosis imaging during and post-radiation therapy (RT) in cervical-cancer and prostate-cancer patients, using non-contrast and Late-Gadolinium-Enhanced IR-UTE.
Goal(s): We now focus on early response to low radiation dose, validating that fibrosis imaging is an early marker allowing for changing dose-distribution during treatment to improve tumor response
Approach: We compare hypoxic and normoxic swine fibrosis 1-3 weeks post-10Gy radiation, as hypoxia reduces RT response, and show histology-slides illustrating differences between diffuse- and dense-fibrosis. We also show weekly fibrosis imaging during 0-22Gy radiotherapy, in cervical-cancer patients.
Results: Diffuse-fibrosis&Dense-fibrosis increase after 5Gy radiation and track tumor-shrinkage, serving as markers of tumor response.
Impact: Tumor response can differ widely between patients, even when receiving the same RT. If the response can be predicted early-on, treatment can be modified to improve outcome. We show that fibrosis imaging serves as a sensitive early marker of radiation-response.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords